Is Korsana Biosciences, Inc. overvalued?

Korsana Biosciences, Inc. (KRSA) — key valuation metrics and fundamentals.

No verdict

Price

$23.20

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$108.6M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares KRSA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 10 Sep 2026.

Related stocks